John David Sinden

John David Sinden

Founder at Glialign Ltd.

73 year
Commercial Services
Consumer Services
Electronic Technology

Profile

John David Sinden was the founder of ReNeuron Group Plc, founded in 1997 where he held the title of Executive Director & Chief Scientific Officer until 2015, and Glialign Ltd., founded in 2018 where he previously held the title of Chief Executive Officer & Director.
Dr. Sinden's current jobs include being a member of the International Society for Cellular Therapy, The Royal Society of Medicine, Society For Neuroscience, and The International Society for Stem Cell Research.
Dr. Sinden's former job was as Director-Business Development at Telsis Group Ltd.
Dr. Sinden's education history includes an undergraduate degree from The University of Sydney and a doctorate degree from Université Pierre et Marie Curie.

John David Sinden active positions

CompaniesPositionStart
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
The International Society for Stem Cell Research Corporate Officer/Principal -
Founder 2017-12-31
All active positions of John David Sinden

Former positions of John David Sinden

CompaniesPositionEnd
RENEURON GROUP PLC Founder -
Corporate Officer/Principal -
See the detail of John David Sinden's experience

Training of John David Sinden

The University of Sydney Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John David Sinden's experience

Connections

100 +

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
RENEURON GROUP PLC

Health Technology

Private companies7

Electronic Technology

Commercial Services

Commercial Services

Commercial Services

The International Society for Stem Cell Research

Commercial Services

Université Pierre et Marie Curie

Consumer Services

See company connections
  1. Stock Market
  2. Insiders
  3. John David Sinden
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW